(2)Cleveland Clinic Mellen Center Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: (2)Cleveland Clinic Mellen Center

Poster-Disease-modifying Therapy

October 25, 2021

Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients with Relapsing Multiple Sclerosis

Background: Ozanimod is approved in the US for the treatment of adults with relapsing multiple sclerosis (RMS) and in the EU and Canada for...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC